Applied Spectra’s LAMIS Technology Wins 2012 R&D 100 Award

Fremont, Calif. (June 22, 2012) – Applied Spectra announced today that its Laser Ablation Molecular Isotopic Spectrometry (LAMIS) technology, co-developed with Lawrence Berkeley National Laboratory, has received the 2012 R&D 100 Award.

2012 R&D100

The award, selected by an independent judging panel and the editors of R&D Magazine, recognizes the 100 most technologically significant products introduced in the past year.

LAMIS is an innovative laser ablation plasma spectroscopic technique for isotopic analysis. Similar to LIBS, the emitted light from a laser ablation plume is collected and analyzed. However, in the case of LAMIS, molecular emission lines are used for the isotopic analysis.

LAMIS shares all same technical benefits of LIBS, including rapid analysis time and the elimination of sample preparation involving toxic acids. LAMIS is suited for determination of isotopic ratios of elements important in environmental, nuclear, and medical applications (such as Carbon, Nitrogen, Boron, Strontium, etc).

“We are very honored to receive the 2012 R&D Award. This award signifies the huge potential of LAMIS for a variety of applications,” said Dr. Rick Russo, CEO and President of Applied Spectra. “We look forward to the continued advancement of LAMIS and enabling the technology for numerous practical applications.”

The list of 2012 R&D 100 winners are available at

Other News and Awards for LAMIS Technology

LAMIS was highlighted in a News Center article at Lawrence Berkeley National Laboratory in March, 2012. To read the article, click:

Additionally, LAMIS won a FACSS Innovation Award during the SCIX 2011 Conference in Reno, NV. See: